Toronto General Hospital, University Health Network
Toronto General Hospital, University Health Network
Toronto, Ontario, Canada6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Enrolling by invitation | Phase 4 | 2026-10-08 | NCT05185505 | |
| A2 to O Lung Transplants | ABO Incompatibility; Lung Transplant | Recruiting | Not applicable | 2026-09-29 | NCT05581745 | |
| A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) | Transfusion-dependent Alpha-Thalassemia; Transfusion-dependent Beta-Thalassemia | Active, not recruiting | Phase 3 | 2026-09-28 | NCT04770779 | |
| Non-ablative Oligofractionated Radiation Therapy Before Surgical Transplantation As Radiovaccination | Transplant-Related Lung Cancer | Recruiting | Not applicable | 2026-09-10 | NCT04782752 | |
| Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy | Blood-Borne Infections, Chronic Disease, Digestive System Diseases, Disease Attributes, Female Urogenital Diseases and Pregnancy Complications, Flaviviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pregnancy Complications, Infectious, RNA Virus Infections, Urogenital Diseases, chronic hepatitis C virus infection, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, pregnancy disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 4 | 2026-04-15 | NCT05140941 | |
| Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol) | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Not applicable | 2025-05-16 | NCT06668454 |